← Leaderboards
Yuqing Li
University Of Illinois Urbana-Champaign
$8,687,650
Attributed
$9,714,295
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,714,295 · 12
By mechanism
R01$6,550,970 · 4
R21$2,711,825 · 6
R03$451,500 · 2
Top collaborators
- David E Vaillancourt5 shared
Most similar at University Of Illinois Urbana-Champaign
Same institution · by research overlap
- Monica Fabiani$7,258,416
Others in their field
Top investigators on “Functional Disorder”
- Randall J Bateman · Washington University$164,791,794
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- David Heimbrook · Leidos Biomedical Research, Inc.$127,725,513
- Ed Lein · Allen Institute$92,850,604
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- John M Lachin · George Washington University$85,958,868
Research focus
Functional DisorderSymptomsAffectBehavioralProteinsBrainGeneticCorpus Striatum StructureIn VivoNeuronsGenesMovement DisordersMouse ModelDystoniaAnimal ModelEnvironmentInterdisciplinary ApproachFundingMolecular GeneticsKnockout MiceResearch PersonnelPathway InteractionsLeadCells
Grant awards (39)
Pathophysiology of DYT1 dystonia: Targeted Mouse Models$367,646
R01 · FY2025 · NS · contact PI
Supplement: Pathophysiology of DYT1 dystonia: Targeted Mouse Models$76,750
R01 · FY2025 · NS · contact PI
Pathophysiology of DYT1 dystonia: Targeted Mouse Models$354,228
R01 · FY2024 · NS · contact PI
Striatal Contribution to the Motor Symptoms and Aphasia in GRN-FTD$305,000
R03 · FY2024 · AG · contact PI
Pathophysiology of DYT1 dystonia: Targeted Mouse Models$362,945
R01 · FY2023 · NS · contact PI
Non-Invasive Markers of Neurodegeneration in Movement Disorders$410,658
R01 · FY2022 · NS
Pathophysiology of DYT1 dystonia: Targeted Mouse Models$360,910
R01 · FY2022 · NS · contact PI
Non-Invasive Markers of Neurodegeneration in Movement Disorders$410,658
R01 · FY2021 · NS
Characterization of Meis1 mutant mice and implications in restless legs syndrome and other sleep disorders$190,625
R21 · FY2021 · NS · contact PI
Characterization of the involvement of the cerebellum in animal models of C9orf72 ALS/FTD$419,375
R21 · FY2020 · NS · contact PI
Non-Invasive Markers of Neurodegeneration in Movement Disorders$410,658
R01 · FY2020 · NS
Characterization of Meis1 mutant mice and implications in restless legs syndrome and other sleep disorders$228,750
R21 · FY2020 · NS · contact PI
Non-Invasive Markers of Neurodegeneration in Movement Disorders$410,658
R01 · FY2019 · NS
Non-Invasive Markers of Neurodegeneration in Movement Disorders$410,658
R01 · FY2018 · NS
Restless Legs Syndrome: Pathophysiology using Btbd9 Conditional Knockout Mice$302,323
R01 · FY2018 · NS · contact PI
Restless Legs Syndrome: Pathophysiology using Btbd9 Conditional Knockout Mice$314,379
R01 · FY2017 · NS · contact PI
Restless Legs Syndrome: Pathophysiology using Btbd9 Conditional Knockout Mice$323,343
R01 · FY2016 · NS · contact PI
Restless Legs Syndrome: Pathophysiology using Btbd9 Conditional Knockout Mice$338,695
R01 · FY2015 · NS · contact PI
Restless Legs Syndrome: Pathophysiology using Btbd9 Conditional Knockout Mice$327,580
R01 · FY2014 · NS · contact PI
Characterization of epsilon-sarcoglycan interacting proteins in mouse brain$73,250
R03 · FY2012 · NS · contact PI
Rapid-onset Dystonia Parkinsonism (DYT12 Dystonia): Pathophysiology & Atp1a3 Mice$179,463
R21 · FY2011 · NS · contact PI
Characterization of epsilon-sarcoglycan interacting proteins in mouse brain$73,250
R03 · FY2011 · NS · contact PI
Pathophysiology of DYT1 Dystonia: Targeted Mouse Models$228,920
R01 · FY2010 · NS · contact PI
Pathophysiology and Animal Model of Restless Legs Syndrome (RLS): Btbd9 Null Mic$181,294
R21 · FY2010 · NS · contact PI
Rapid-onset Dystonia Parkinsonism (DYT12 Dystonia): Pathophysiology & Atp1a3 Mice$161,150
R21 · FY2010 · NS · contact PI
Pathophysiology of DYT1 Dystonia: Targeted Mouse Models$112,276
R01 · FY2010 · NS · contact PI
Rapid-onset Dystonia Parkinsonism (DYT12 Dystonia): Pathophysiology & Atp1a3 Mice$58,000
R21 · FY2010 · NS · contact PI
Pathophysiology of DYT1 Dystonia: Targeted Mouse Models$307,507
R01 · FY2009 · NS · contact PI
Pathophysiology and Animal Model of Restless Legs Syndrome (RLS): Btbd9 Null Mic$219,750
R21 · FY2009 · NS · contact PI
Pathophysiology of DYT1 Dystonia: Targeted Mouse Models$42,413
R01 · FY2009 · NS · contact PI
Pathophysiology of DYT1 Dystonia: Targeted Mouse Models$325,707
R01 · FY2008 · NS · contact PI
Pathophysiology of DYT1 Dystonia: Targeted Mouse Models$352,058
R01 · FY2007 · NS · contact PI
Pathophysiology of Myoclonas-Dystonia: Sgce Mutant Mice$119,919
R21 · FY2006 · NS · contact PI
Pathophysiology of Myoclonas-Dystonia: Sgce Mutant Mice$52,830
R21 · FY2006 · NS · contact PI
Pathophysiology of Myoclonas-Dystonia: Sgce Mutant Mice$210,639
R21 · FY2005 · NS
Animal model of juvenile epileptogenesis: NMDA receptors$224,910
R21 · FY2004 · NS
Animal model of juvenile epileptogenesis: NMDA receptors$15,300
R21 · FY2004 · NS
Animal model of juvenile epileptogenesis: NMDA receptors$224,910
R21 · FY2003 · NS
Animal model of juvenile epileptogenesis: NMDA receptors$224,910
R21 · FY2002 · NS